KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to $105.4 million.

  • Sarepta Therapeutics' Shares Outstanding rose 1039.45% to $105.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.4 million, marking a year-over-year increase of 1039.45%. This contributed to the annual value of $96.9 million for FY2024, which is 337.98% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Shares Outstanding stood at $105.4 million for Q3 2025, which was up 1039.45% from $98.4 million recorded in Q2 2025.
  • Sarepta Therapeutics' Shares Outstanding's 5-year high stood at $105.4 million during Q3 2025, with a 5-year trough of $79748.0 in Q1 2021.
  • Over the past 5 years, Sarepta Therapeutics' median Shares Outstanding value was $87.5 million (recorded in 2022), while the average stood at $54.8 million.
  • In the last 5 years, Sarepta Therapeutics' Shares Outstanding crashed by 9989.85% in 2021 and then surged by 10966375.39% in 2022.
  • Over the past 5 years, Sarepta Therapeutics' Shares Outstanding (Quarter) stood at $87127.0 in 2021, then grew by 0.94% to $87950.0 in 2022, then surged by 106474.19% to $93.7 million in 2023, then increased by 3.38% to $96.9 million in 2024, then grew by 8.79% to $105.4 million in 2025.
  • Its last three reported values are $105.4 million in Q3 2025, $98.4 million for Q2 2025, and $98.3 million during Q1 2025.